<i>Salvia officinalis</i> L.: Antitrypanosomal Activity and Active Constituents against <i>Trypanosoma brucei rhodesiense</i>

• Published in: Molecules
• Main Authors: Núria Llurba Montesino, Marcel Kaiser, Pascal Mäser, Thomas J. Schmidt
• Format: Article
• Language: English
• Published: MDPI AG 2021-05-01
• Subjects: <i>Salvia officinalis</i> L.; <i>Trypanosoma brucei rhodesiense</i>; antitrypanosomal activity; diterpene; abietane; rosmanol derivative
• Online Access: https://www.mdpi.com/1420-3049/26/11/3226

As part of our studies on antiprotozoal activity of approved herbal medicinal products, we previously found that a commercial tincture from <i>Salvia officinalis</i> L. (common Sage, Lamiaceae) possesses high activity against <i>Trypanosoma brucei rhodesiense (Tbr)</i>, causative agent of East African Human Trypanosomiasis. We have now investigated in detail the antitrypanosomal constituents of this preparation. A variety of fractions were tested for antitrypanosomal activity and analyzed by UHPLC/+ESI QqTOF MS. The resulting data were used to generate a partial least squares (PLS) regression model that highlighted eight particular constituents that were likely to account for the major part of the bioactivity. These compounds were then purified and identified and their activity against the pathogen tested. All identified compounds (one flavonoid and eight diterpenes) displayed significant activity against <i>Tbr</i>, in some cases higher than that of the total tincture. From the overall results, it can be concluded that the antitrypanosomal activity of <i>S. officinalis</i> L. is, for the major part, caused by abietane-type diterpenes of the rosmanol/rosmaquinone group.